Abstract:Background: Esophageal squamous cell carcinoma (ESCC), a prevalent malignancy within the upper gastrointestinal system, is characterized by its unfavorable prognosis and the absence of specific indicators for outcome prediction and high-risk case identification. In our research, we examined the expression levels of cancer stem cells (CSCs), markers CD44/SOX2 in ESCC, scrutinized their association with clinicopathological parameters, and developed a predictive nomogram model. This model, which incorporates CD44/SOX2, aims to forecast the overall survival (OS) of patients afflicted with ESCC. Methods: Immunohistochemistry was utilized to detect the expression levels of CD44 and SOX2 in both cancerous and paracancerous tissues of 68 patients with ESCC. The correlation between CD44/SOX2 expression and clinicopathological parameters was subsequently analyzed. Factors impacting the prognosis of ESCC patients were assessed through univariate and multivariate Cox regression analyses. Leveraging the results of these multivariate regression analyses, a nomogram prognostic model was established to provide individualized predictions of ESCC patient survival outcomes. The predictive accuracy of the nomogram prognostic model was evaluated using the consistency index (C-index) and calibration curves. Results: The expression levels of CD44 were markedly elevated in the tumor tissues of ESCC patients. Similarly, SOX2 was significantly overexpressed in the tumor tissues of ESCC patients. The positive expression of SOX2 in ESCC demonstrated a strong correlation with both the pathological T-stage and the presence of carcinoembryonic antigen. CD44 and SOX2 co-positive expression was significantly associated with the pathological T-stage and tumor node metastasis (TNM) stage. Furthermore, ESCC patients exhibiting CD44-positive expression in their tumor tissue generally had a more adverse prognosis. The co-expression of CD44 and SOX2 resulted in a grimmer prognosis compared to patients with other combinations. Multivariate Cox regression analysis identified the co-expression of CD44 and SOX2, the pathological T-stage, and lymph node metastasis as independent prognostic indicators for ESCC patients. The three identified variables were subsequently incorporated into a nomogram for predicting OS. The C-index of the measurement model and the area under the curve of the subjects' work characteristics showed good individual prediction. This prognostic model stratified patients into low- and high-risk categories. Analysis revealed that the 5-year OS rate was significantly higher in the low-risk group compared to the high-risk group. Conclusions: Elevated CD44 levels, indicative of CSC presence, are intimately linked with the oncogenesis of ESCC and are strongly predictive of unfavorable patient outcomes. Concurrently, the SOX2 gene exhibits a heightened expression in ESCC, markedly accelerating tumor progression and fostering more extensive disease infiltration. The co-expression of CD44 and SOX2 correlates significantly with ESCC patient prognosis, serving as a reliable, independent prognostic marker. Our constructed nomogram, incorporating CD44/SOX2 expression, enhances the prediction of OS and facilitates risk stratification in ESCC patients.

Oct4 Positively Regulates Survivin Expression To Promote Cancer Cell Proliferation And Leads To Poor Prognosis In Esophageal Squamous Cell Carcinoma

Expression of OCT4 in Human Esophageal Squamous Cell Carcinoma is Significantly Associated with Poorer Prognosis

Prognostic Value of Association of OCT4 with LEF1 Expression in Esophageal Squamous Cell Carcinoma and Their Impact on Epithelial‐mesenchymal Transition, Invasion, and Migration

Genome-Wide DNA Methylation and Gene Expression Profiling Characterizes Molecular Subtypes of Esophagus Squamous Cell Carcinoma for Predicting Patient Survival and Immunotherapy Efficacy

Expression of Oct-4 Transcriptional Factor Rregulates the Anti-Apoptosis Effect of Survivin in Hepatobiliary Cancer Cells

THE EXPRESSION AND CLINICAL SIGNIFICANCE OF SURVIVIN AND VASCULAR ENDOTHELIAL GROWTH FACTOR IN ESOPHAGEAL CANCER

Expressions of HIF-1α and Survivin in Esophageal Squamous Cell Carcinoma and Their Effect on Prognosis after Radiotherapy

CDK4 Amplification in Esophageal Squamous Cell Carcinoma Associated with Better Patient Outcome

Relationship Between Survivin Expression and Chemoradiotherapy Response in Esophageal Squamous Cell Carcinoma

Clinicopathological Significance Of Sox4, Beta-Catenin, And Tcf4 Expression In Esophageal Squamous Cell Carcinoma

The clinical significance of p53 and pRb signal pathway in esophageal cancer patients

Expression and Clinical Significance of HIF-1α, VEGF and Survivin in Esophageal Squamous Cell Carcinoma

Expression and localization of survivin associates with cell proliferation, apoptosis and the prognosis significance in squamous cell carcinoma of esophagus

Clinicopathological And Prognostic Significance Of Survivin Over-Expression In Patients With Esophageal Squamous Cell Carcinoma: A Meta-Analysis

Over-expression of Oct4 in human esophageal squamous cell carcinoma

[Expression of Survivin and Its Significance in Esophageal Cancer].

Clinicopathological and Predictive Significance of SIRT1 and Peroxisome Proliferator-Activated Receptor Gamma in Esophageal Squamous Cell Carcinoma: the Correlation with EGFR and Survivin.

Oncolytic adenovirus-mediated dual knockdown of survivin and OCT4 improves therapeutic efficacy in esophageal cancer.

Expressions of Oct4 and Sox2 Protein and Their Correlations in Esophageal Squamous Cell Carcinoma

[Expression of Six1 and Six4 in esophageal squamous cell carcinoma and their correlation with clinical prognosis].

Clinicopathological significance of cancer stem cell marker CD44/SOX2 in esophageal squamous cell carcinoma (ESCC) patients and construction of a nomogram to predict overall survival